A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
150
Participants
Timeline
Start Date
April 30, 2003
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2004
Conditions
Infertility Implantation Failure
Interventions
DRUG
Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)
All Listed Sponsors
lead
Merck KGaA, Darmstadt, Germany
INDUSTRY
NCT00504608 - A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure | Biotech Hunter | Biotech Hunter